home / stock / ew / ew news


EW News and Press, Edwards Lifesciences Corporation From 05/06/24

Stock Information

Company Name: Edwards Lifesciences Corporation
Stock Symbol: EW
Market: NYSE
Website: edwards.com

Menu

EW EW Quote EW Short EW News EW Articles EW Message Board
Get EW Alerts

News, Short Squeeze, Breakout and More Instantly...

EW - Overweight Recommendation Issued On EW By Barclays

2024-05-06 21:30:02 ET Barclays analyst issues OVERWEIGHT recommendation for EW on May 6, 2024 08:09PM ET. The previous analyst recommendation was Overweight. EW was trading at $85.09 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...

EW - Goldman's top 50 Strong Balance Sheet stocks

2024-05-05 15:10:28 ET More on the markets S&P 500 1%+ Gaps Higher SPY: Don't Buy The Dip Just Yet Rate Hike Unlikely: Expect S&P 500 To Rally To New All-Time Highs Data Insight: April's jobs report was biggest disappointment in at least 2 years ...

EW - Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Call Transcript

2024-04-25 21:19:07 ET Edwards Lifesciences Corporation (EW) Q1 2024 Earnings Conference Call April 25, 2024 05:00 PM ET Company Participants Mark Wilterding - SVP & IR Bernard Zovighian - CEO Scott Ullem - CFO Daveen Chopra - Global Leader of TMTT La...

EW - Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M

2024-04-25 16:18:53 ET More on Edwards Lifesciences Read the full article on Seeking Alpha For further details see: Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M

EW - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

EW - Edwards Lifesciences Q1 2024 Earnings Preview

2024-04-24 17:20:27 ET More on Edwards Lifesciences Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained) Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript BofA upgrades Edwards to buy, says double-digit growth is ...

EW - Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877...

EW - EW Price Target Alert: $101.00. Issued by RBC Capital

2024-04-15 10:00:02 ET Shagun Singh from RBC Capital issued a price target of $101.00 for EW on 2024-04-15 08:08:00. The adjusted price target was set to $101.00. At the time of the announcement, EW was trading at $90.28. The overall price target consensus is at $111.78 ...

EW - Wedgewood Partners Q1 2024 Client Letter

2024-04-13 09:10:00 ET Summary Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. The year 2024 is off to a near-historic start with the S&P 500 Index gaining +10.5% during the ...

EW - Top quant-rated consumer staples during Q1

2024-04-11 12:17:00 ET More on Consumer Staples XLP: Expensive With Underperformance Risk XLP: Rotate Into This Lagging Sector These are the most crowded longs within consumer staples - UBS Top buy-rated stocks in consumer staples - Citi Read the fu...

Previous 10 Next 10